Dupilumab therapy in children aged 2 to 12 years with uncontrolled moderate-to-severe atopic dermatitis: a Chinese real-world study.
Bingjing ZhouCong PengQiaozhi CaoJiayi WangXiang ChenRunqiu LiuPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)